edison tv
Investment Companies
“Edison is the go-to for a new investor to get full understanding of the investment case and business. Edison’s distribution reaches investors that we want to connect with directly.”
BB Biotech’s portfolio company, Nuvalent (focused on targeted oncology), has been acquired by GSK for $124 per share, with aggregate equity value of the transaction at approximately $10.6bn. At end-Q126, Nuvalent represented 3.8% of BB Bitoech’s portfolio. BB Biotech noted that the transaction highlights the continued demand for innovative biotechs with differentiated clinical assets, reinforcing the strong M&A environment within the healthcare sector.
Industrials | Comment
TMT | Comment
Industrials | Comment
Industrials | Comment
Get access to the very latest content matched to your personal investment style.